BMN-307
- Generic Name
- BMN-307
AAV Gene Therapy Study for Subjects with PKU
- First Posted Date
- 2020-07-21
- Last Posted Date
- 2024-12-12
- Lead Sponsor
- BioMarin Pharmaceutical
- Target Recruit Count
- 100
- Registration Number
- NCT04480567
- Locations
- 🇺🇸
University of South Florida, Tampa, Florida, United States
🇺🇸Morristown Medical Center, Morristown, New Jersey, United States
🇬🇧University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath